Moderna names former PerkinElmer exec as new CFO
Tweet
Share
E-mail
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder/File Photo
(Reuters) - Moderna Inc on Wednesday named former PerkinElmer executive James Mock as its new finance chief, months after the abrupt exit of former CFO Jorge Gomez.
The COVID-19 vaccine maker had appointed Dentsply Sirona's Gomez as finance chief in April, but he left his position a day after taking charge the next month.
Gomez's departure followed an investigation launched by his former employer, Moderna said.
Following the exit, former Moderna CFO David Meline returned from his recent retirement to take over the role.
Moderna on Wednesday said Mock would start as finance chief from Sept. 6. Meline would retire on the same day but shall remain as a consultant through the transition.
Before joining Moderna, Mock was the chief financial officer of PerkinElmer, a life sciences and diagnostics company.
(Reporting by Amruta Khandekar; Editing by Devika Syamnath)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Comments on Moderna (MRNA) Collaboration with OpenAI
- Ciena (CIEN) Announces Retirement of Principal Accounting Officer Andrew C. Petrik
- Moderna (MRNA) Collaborates with OpenAI
Create E-mail Alert Related Categories
General News, Management Changes, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
